Vaginal Estrogen: What It Is and Why Your GP Should Offer It

The short answer: if intimacy has turned painful, sex feels like sandpaper, or you keep getting urinary infections after 45, low-dose vaginal estrogen (oestrogen) is often the treatment that fixes it, and it is safe enough that most women can stay on it for years. It is a small dose of estrogen delivered as a cream, pessary, tablet or ring directly into the vagina, where it rebuilds the thinning tissue that falling hormones leave behind. Because it acts locally and barely enters the bloodstream, it does not carry the risks people associate with systemic hormone therapy, it does not need added progesterone, and it can be used by many women who cannot or choose not to take standard HRT. If you have been told to “just use lube” and sent away, that advice was incomplete, and you are entitled to ask again.

This is one of the most under-prescribed treatments in menopause care, which is striking given how well it works and how safe it is. The symptoms it treats are common, treatable, and quietly miserable, and too many women are told they are part of getting older. They are not. Below is what vaginal estrogen is, what it treats, why the safety profile is so different from systemic HRT, and how to ask for it clearly if the first conversation goes nowhere.

What vaginal estrogen is and what it treats

Vaginal estrogen is a low dose of estrogen applied directly inside the vagina rather than swallowed or absorbed through the skin of the body. The cluster of symptoms it treats has a name: genitourinary syndrome of menopause, or GSM. This is the modern umbrella term for what used to be called vaginal atrophy, and it covers vaginal dryness, burning and itching, pain during sex, and a set of urinary symptoms including frequency, urgency, and recurrent urinary tract infections. All of it traces back to one cause: the vaginal and bladder tissues are rich in estrogen receptors, and when estrogen falls in perimenopause and menopause, those tissues thin, lose elasticity, and become more fragile and easily irritated.

The reason local treatment matters is that lubricants and moisturisers, useful as they are, only sit on the surface. As one clinician put it plainly, they grease the skids but do not change the tissue. Vaginal estrogen is different because it treats the underlying cause. It thickens the vaginal lining, restores natural moisture and the healthy acidic pH, and improves the tissue’s resilience over time. That is why it can resolve symptoms that no amount of lubricant fully touches. For a fuller picture of the symptom cluster itself, our guide to vaginal dryness and GSM sits alongside this one.

The four forms, and how they differ

Vaginal estrogen comes in several formats, and they are broadly equivalent in effectiveness, so the choice usually comes down to preference, convenience and cost. Some women find a nightly cream messy and prefer a tablet or ring; others like being able to apply a cream precisely to the vulva as well as inside. There is no single “best” form, and it is reasonable to try one and switch if it does not suit you.

Form	How it is used	Notes
Cream	Applied with an applicator, or by finger to the vulva, usually nightly then a few times a week	Flexible dosing; can treat external vulval tissue directly; some find it messy
Pessary or tablet	Small tablet inserted into the vagina, typically nightly then twice weekly	Tidy and low-mess; fixed low dose; widely available
Vaginal ring	Soft ring sits high in the vagina, releasing a steady low dose	Changed every three months; nothing to remember daily; discreet
DHEA pessary	A precursor the body converts locally to estrogen and testosterone	An alternative where estrogen is unsuitable; discuss with a specialist

Most regimens start with more frequent use to build the tissue back up, usually nightly for the first couple of weeks, then settle to a maintenance dose of roughly twice a week. Your prescriber will set the exact schedule.

Why it does not carry the risks of systemic HRT

This is the point that changes the conversation, so it is worth being precise. Systemic HRT, whether patch, gel or tablet, raises estrogen levels throughout the whole body to treat symptoms like hot flashes (hot flushes), mood changes and bone loss. Vaginal estrogen does something narrower: it delivers a tiny dose that works on the local tissue with only minimal absorption into the bloodstream. Blood estrogen levels in women using it typically stay within the normal postmenopausal range.

Two practical consequences follow. First, according to The Menopause Society position statement on GSM, low-dose vaginal estrogen does not require the addition of progesterone. Progesterone is added to systemic estrogen to protect the lining of the womb; because local vaginal estrogen does not meaningfully raise whole-body estrogen, that protection is not needed. If a clinician tells you that you must take progesterone alongside vaginal estrogen, that is a common misunderstanding worth gently correcting. Second, because the systemic exposure is so low, the safety profile is reassuring enough that it is considered suitable for long-term use, which matters because GSM is chronic.

It is different from systemic HRT, and can be used alongside it

A frequent point of confusion is that women think they have to choose between vaginal estrogen and systemic HRT. They do not. These are different tools for different jobs, and many women use both at once. Systemic HRT treats the body-wide symptoms of menopause. Vaginal estrogen treats the genital and urinary tissue specifically, and it does this better than systemic HRT alone, because even women on full-dose HRT sometimes still have vaginal and bladder symptoms that need direct local treatment.

So if you are already on HRT and still experiencing dryness, painful sex or recurrent infections, adding vaginal estrogen is entirely standard and not a contradiction. Equally, if you cannot take or do not want systemic HRT, vaginal estrogen on its own is a complete treatment for GSM. Low libido often travels with these physical symptoms, and treating the discomfort can be part of the picture; our guide to low libido in perimenopause looks at the wider causes.

Vaginal estrogen after breast cancer

This is where women are most often turned away, and where the nuance matters most. The reassuring headline, supported by specialist bodies including the British Menopause Society, is that many women who have had breast cancer can safely use vaginal estrogen for troublesome GSM, because the local dose and minimal systemic absorption make the risk very different from systemic HRT. Recent evidence has been broadly reassuring on safety and, in some analyses, on survival.

There is an important caveat that a good clinician will raise. The picture differs by treatment type. For women on tamoxifen, vaginal estrogen is generally considered acceptable when symptoms are severe. For women on aromatase inhibitors, which work by lowering estrogen throughout the body, there is more caution, and non-hormonal options are usually tried first. This is precisely why it should be a shared decision made together with your oncology team rather than settled in a single primary care appointment. The point is not that vaginal estrogen is automatically safe or unsafe after breast cancer; it is that a blanket “no” is outdated, and you are entitled to a proper specialist discussion.

How long it takes, and why symptoms return if you stop

Vaginal estrogen is not an overnight fix, and setting expectations helps. Most women notice some improvement within a few weeks, with fuller benefit building over roughly eight to twelve weeks as the tissue rebuilds. For recurrent urinary tract infections specifically, the evidence is encouraging: sustained use can reduce the frequency of infections substantially over time, which is why NICE guideline NG23 supports considering vaginal estrogen for postmenopausal women with GSM and recurrent UTIs.

The other thing to understand is that GSM is a chronic condition, driven by an ongoing lack of estrogen in the tissue. That means vaginal estrogen manages it rather than cures it, and symptoms tend to return within a few months if you stop. This is not a sign of dependence or a problem with the treatment; it is how a maintenance therapy works, in the same way that stopping a moisturiser lets dry skin return. Because the long-term safety profile is reassuring, staying on it indefinitely is a reasonable and common plan.

At Yellow we hear constantly from women who were dismissed on this exact issue, then finally got treated and wished they had pushed sooner. You can find more plain-language guides on the Yellow blog, and the section below sets out how to ask so that you are not fobbed off again.

Frequently Asked Questions

Is vaginal estrogen safe to use long-term?

Yes, for most women. Because the dose is low and stays largely in the local tissue with minimal absorption into the bloodstream, the safety profile is very different from systemic HRT. The Menopause Society considers long-term use appropriate, which matters because genitourinary syndrome of menopause is chronic and symptoms return if treatment stops.

Do I need to take progesterone with vaginal estrogen?

No. Progesterone is added to systemic estrogen to protect the lining of the womb, but low-dose vaginal estrogen does not raise whole-body estrogen enough to require it. If a clinician insists you need progesterone alongside a local vaginal preparation, this is a common misunderstanding, and it is reasonable to ask them to check current guidance.

How long does vaginal estrogen take to work?

Most women feel some improvement within a few weeks, with fuller benefit building over about eight to twelve weeks as the tissue rebuilds. For recurrent urinary tract infections, benefit accumulates over months rather than days. If you have seen no change at all after roughly three months of consistent use, it is worth returning to your prescriber to review.

Can I use vaginal estrogen if I have had breast cancer?

Often, yes, but it should be a shared decision with your oncology team. Specialist bodies note that many breast cancer survivors can use it safely for significant GSM, given the minimal systemic absorption. The nuance depends on your treatment: it is generally more acceptable on tamoxifen and approached with more caution on aromatase inhibitors.

Is vaginal estrogen the same as HRT?

Not quite. Systemic HRT raises estrogen throughout the body to treat symptoms like hot flashes and mood changes. Vaginal estrogen treats the genital and urinary tissue locally with minimal systemic effect. They are different tools, and many women use both at once, adding local treatment when HRT alone does not resolve dryness or urinary symptoms.

My GP said to just use lubricant. What should I do?

Lubricants and moisturisers help symptoms but do not change the underlying tissue, so they are often not enough on their own. It is reasonable to go back and ask specifically about a prescription for vaginal estrogen for genitourinary syndrome of menopause. Naming the condition and the treatment clearly tends to move the conversation forward.